Author

Anat Gelfand

Technion – Israel Institute of Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:mechanistic / dynamical model· 1 Organism:mouse· 1

Frequent Co-Authors

David MeiriiD· 1 shared Elazar BesseriD· 1 shared Paula BermaniD· 1 shared Shiri Procaccia· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

David MeiriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyeLifePeer-reviewedDec 14, 2023

Cannabinoid Combination Targets NOTCH1-Mutated T-ALL Through the Integrated Stress Response Pathway

Elazar Besser, Anat Gelfand, Shiri Procaccia…·David Meiri

This study identifies three cannabinoids that target NOTCH1-mutated T-ALL by activating the integrated stress response pathway, reducing Notch1 activity, and inducing apoptosis.

16 citations

mousebulk RNA-seq

𝕏 PostBluesky